Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
出版年份 2018 全文链接
标题
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
作者
关键词
-
出版物
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245851876566
出版商
SAGE Publications
发表日期
2018-03-15
DOI
10.1177/1352458518765666
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Longitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: A pilot study
- (2017) René-Maxime Gracien et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study
- (2017) Arianna Sartori et al. JOURNAL OF NEUROLOGY
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Serum neurofilament is associated with progression of brain atrophy and disability in early MS
- (2017) Jens Kuhle et al. NEUROLOGY
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Long-term evolution of multiple sclerosis disability in the treatment era
- (2016) et al. ANNALS OF NEUROLOGY
- The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
- (2016) Lukas Haider et al. BRAIN
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab
- (2016) Pierre de Flon et al. NEUROLOGY
- Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?
- (2016) Catherine Larochelle et al. TRENDS IN NEUROSCIENCES
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
- (2015) J. Kuhle et al. NEUROLOGY
- Disease Activity Free Status
- (2014) Carolyn J. Bevan et al. JAMA Neurology
- Neurofilaments as biomarkers in multiple sclerosis
- (2012) Charlotte E Teunissen et al. Multiple Sclerosis Journal
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started